Brainstorm Cell Therapeutics Inc. - Common Stock (BCLI)

Brainstorm Cell just reported results for the first quarter of 2024.

BCLI stock results show that Brainstorm Cell missed analyst estimates for earnings per share the second quarter of 2024.

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news for Wednesday morning!

Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

BCLI stock results show that Brainstorm Cell beat analyst estimates for earnings per share the fourth quarter of 2023.

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

BioRestorative Therapies (NASDAQ: BRTX) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions such as obesity and diabetes.

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales